$ESRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Express Scripts Holding Co..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Express Scripts Holding Co.. Get notifications about new insider transactions in Express Scripts Holding Co. for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Option Exercise | D | 84.08 | 5,604 | 471,184 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Option Exercise | D | 67.05 | 6,402 | 429,254 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Option Exercise | D | 61.58 | 5,872 | 361,598 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Option Exercise | D | 52.53 | 4,580 | 240,587 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Sell | D | 0.00 | 14,989 | 0 | 0 | 15 K to 0 (-100.00 %) |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | D | 60.66 | 8,006 | 485,644 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | D | 72.74 | 7,032 | 511,508 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | D | 84.08 | 5,604 | 471,184 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | D | 67.05 | 6,402 | 429,254 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | D | 61.58 | 5,872 | 361,598 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | D | 52.53 | 6,870 | 360,881 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Sell | D | 0.00 | 27,305 | 0 | 0 | 27.3 K to 0 (-100.00 %) |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | ARLOTTA JOHN | CEO, eviCore health ... | Sell | D | 0.00 | 6,688 | 0 | 0 | 6.7 K to 0 (-100.00 %) |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | D | 0.00 | 340 | 0 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | D | 67.62 | 23,627 | 1,597,658 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | D | 69.57 | 24,367 | 1,695,212 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | D | 86.38 | 14,420 | 1,245,600 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | D | 84.83 | 6,722 | 570,227 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | D | 77.15 | 4,264 | 328,968 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Sell | D | 0.00 | 17,317 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 0.00 | 461 | 0 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 67.62 | 47,254 | 3,195,315 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 69.57 | 48,735 | 3,390,494 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 86.82 | 34,909 | 3,030,799 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 84.83 | 5,626 | 477,254 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 77.15 | 5,946 | 458,734 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 58.17 | 4,280 | 248,968 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 53.54 | 1,547 | 82,826 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | D | 53.05 | 1,964 | 104,190 | 0 | |
| Dec 21 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Sell | D | 0.00 | 46,219 | 0 | 0 | 46.2 K to 0 (-100.00 %) |
| Dec 04 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 101.47 | 165 | 16,743 | 43,800 | 44 K to 43.8 K (-0.38 %) |
| Dec 04 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Gift | G | 0.00 | 20,097 | 0 | 43,965 | 64.1 K to 44 K (-31.37 %) |
| Dec 04 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Payment of Exercise | F | 101.47 | 1,043 | 105,833 | 46,219 | 47.3 K to 46.2 K (-2.21 %) |
| Dec 04 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Gift | G | 0.00 | 1,721 | 0 | 47,262 | 49 K to 47.3 K (-3.51 %) |
| Nov 26 2018 | ESRX | Express Scripts Ho ... | Seiz Brian | Sr. VP, Specialty | Payment of Exercise | F | 95.33 | 381 | 36,321 | 32,118 | 32.5 K to 32.1 K (-1.17 %) |
| Nov 09 2018 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Sell | S | 99.50 | 5,234 | 520,793 | 0 | 5.2 K to 0 (-100.00 %) |
| Nov 09 2018 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Gift | G | 0.00 | 5,234 | 0 | 5,234 | 0 to 5.2 K |
| Nov 09 2018 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Gift | G | 0.00 | 5,234 | 0 | 59,628 | 64.9 K to 59.6 K (-8.07 %) |
| Nov 01 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Payment of Exercise | F | 95.42 | 292 | 27,863 | 17,317 | 17.6 K to 17.3 K (-1.66 %) |
| Oct 30 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Option Exercise | M | 46.70 | 5,464 | 255,169 | 0 | |
| Oct 30 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Payment of Exercise | F | 94.28 | 2,707 | 255,216 | 14,989 | 17.7 K to 15 K (-15.30 %) |
| Oct 30 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Buy | M | 46.70 | 5,464 | 255,169 | 17,696 | 12.2 K to 17.7 K (+44.67 %) |
| Aug 14 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Option Exercise | M | 53.05 | 12,898 | 684,239 | 0 | |
| Aug 14 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Sell | S | 85.00 | 12,898 | 1,096,330 | 98,010 | 110.9 K to 98 K (-11.63 %) |
| Aug 14 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Buy | M | 53.05 | 12,898 | 684,239 | 110,908 | 98 K to 110.9 K (+13.16 %) |
| Jun 15 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Option Exercise | M | 53.05 | 10,000 | 530,500 | 12,898 | |
| Jun 15 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Sell | S | 82.28 | 10,000 | 822,800 | 98,010 | 108 K to 98 K (-9.26 %) |
| Jun 15 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Buy | M | 53.05 | 10,000 | 530,500 | 108,010 | 98 K to 108 K (+10.20 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | STERNBERG SEYMOUR | Director | Grant | A | 0.00 | 2,818 | 0 | 24,613 | 21.8 K to 24.6 K (+12.93 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | ROPER WILLIAM L | Director | Grant | A | 0.00 | 2,818 | 0 | 18,918 | 16.1 K to 18.9 K (+17.50 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Grant | A | 0.00 | 2,818 | 0 | 890,554 | 887.7 K to 890.6 K (+0.32 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | PALMORE RODERICK A | Director | Grant | A | 0.00 | 2,818 | 0 | 7,381 | 4.6 K to 7.4 K (+61.76 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Grant | A | 0.00 | 2,818 | 0 | 14,318 | 11.5 K to 14.3 K (+24.50 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Grant | A | 0.00 | 2,818 | 0 | 38,005 | 35.2 K to 38 K (+8.01 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 2,818 | 0 | 64,862 | 62 K to 64.9 K (+4.54 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Grant | A | 0.00 | 2,818 | 0 | 41,844 | 39 K to 41.8 K (+7.22 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | MAZZARELLA KATHLEEN M | Director | Grant | A | 0.00 | 2,466 | 0 | 2,466 | 0 to 2.5 K |
| May 14 2018 | ESRX | Express Scripts Ho ... | Granger Elder | Director | Grant | A | 0.00 | 2,818 | 0 | 6,523 | 3.7 K to 6.5 K (+76.06 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Grant | A | 0.00 | 2,818 | 0 | 12,232 | 9.4 K to 12.2 K (+29.93 %) |
| May 14 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Grant | A | 0.00 | 2,818 | 0 | 27,305 | 24.5 K to 27.3 K (+11.51 %) |
| May 11 2018 | ESRX | Express Scripts Ho ... | Guerrier Ron | Sr. VP and Chief In ... | Grant | A | 0.00 | 10,199 | 0 | 10,199 | 0 to 10.2 K |
| May 08 2018 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Payment of Exercise | F | 70.22 | 3,537 | 248,368 | 185,064 | 188.6 K to 185.1 K (-1.88 %) |
| May 08 2018 | ESRX | Express Scripts Ho ... | Neville Everett | Exe VP, Strat, Sup ... | Payment of Exercise | F | 70.22 | 522 | 36,655 | 31,049 | 31.6 K to 31 K (-1.65 %) |
| May 01 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | M | 57.59 | 7,466 | 429,967 | 0 | |
| May 01 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Payment of Exercise | F | 76.49 | 5,621 | 429,950 | 24,487 | 30.1 K to 24.5 K (-18.67 %) |
| May 01 2018 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Buy | M | 57.59 | 7,466 | 429,967 | 30,108 | 22.6 K to 30.1 K (+32.97 %) |
| Apr 30 2018 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Option Exercise | M | 57.59 | 7,466 | 429,967 | 0 | |
| Apr 30 2018 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Buy | M | 57.59 | 7,466 | 429,967 | 35,187 | 27.7 K to 35.2 K (+26.93 %) |
| Apr 30 2018 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Option Exercise | M | 57.59 | 7,466 | 429,967 | 0 | |
| Apr 30 2018 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Buy | M | 57.59 | 7,466 | 429,967 | 62,044 | 54.6 K to 62 K (+13.68 %) |
| Apr 30 2018 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Option Exercise | M | 57.59 | 7,466 | 429,967 | 0 | |
| Apr 30 2018 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Buy | M | 57.59 | 7,466 | 429,967 | 39,026 | 31.6 K to 39 K (+23.66 %) |
| Mar 19 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Option Exercise | M | 43.77 | 19,889 | 870,542 | 0 | |
| Mar 19 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Sell | S | 76.69 | 19,889 | 1,525,307 | 98,010 | 117.9 K to 98 K (-16.87 %) |
| Mar 19 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Buy | M | 43.77 | 19,889 | 870,542 | 117,899 | 98 K to 117.9 K (+20.29 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Sample Neal J. | Executive VP & COO | Grant | A | 0.00 | 17,389 | 0 | 43,122 | 25.7 K to 43.1 K (+67.57 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Payment of Exercise | F | 74.58 | 12,808 | 955,221 | 188,601 | 201.4 K to 188.6 K (-6.36 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Grant | A | 0.00 | 28,242 | 0 | 201,409 | 173.2 K to 201.4 K (+16.31 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Grant | A | 0.00 | 80,257 | 0 | 173,167 | 92.9 K to 173.2 K (+86.38 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Payment of Exercise | F | 74.58 | 4,789 | 357,164 | 79,057 | 83.8 K to 79.1 K (-5.71 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Grant | A | 0.00 | 10,560 | 0 | 83,846 | 73.3 K to 83.8 K (+14.41 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Grant | A | 0.00 | 14,714 | 0 | 73,286 | 58.6 K to 73.3 K (+25.12 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Payment of Exercise | F | 74.58 | 1,994 | 148,713 | 45,009 | 47 K to 45 K (-4.24 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Grant | A | 0.00 | 6,385 | 0 | 47,003 | 40.6 K to 47 K (+15.72 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Grant | A | 0.00 | 8,694 | 0 | 40,618 | 31.9 K to 40.6 K (+27.23 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Payment of Exercise | F | 74.58 | 3,316 | 247,307 | 52,799 | 56.1 K to 52.8 K (-5.91 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Grant | A | 0.00 | 8,595 | 0 | 56,115 | 47.5 K to 56.1 K (+18.09 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Grant | A | 0.00 | 14,881 | 0 | 47,520 | 32.6 K to 47.5 K (+45.59 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Phillips Bradley E | VP, Controller and ... | Grant | A | 0.00 | 3,813 | 0 | 14,881 | 11.1 K to 14.9 K (+34.45 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Grant | A | 0.00 | 46,988 | 0 | 887,736 | 840.7 K to 887.7 K (+5.59 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Neville Everett | Exe VP, Strat, Sup ... | Payment of Exercise | F | 74.58 | 1,310 | 97,700 | 31,571 | 32.9 K to 31.6 K (-3.98 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Neville Everett | Exe VP, Strat, Sup ... | Grant | A | 0.00 | 4,316 | 0 | 32,881 | 28.6 K to 32.9 K (+15.11 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Neville Everett | Exe VP, Strat, Sup ... | Grant | A | 0.00 | 17,389 | 0 | 28,565 | 11.2 K to 28.6 K (+155.59 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 74.58 | 3,101 | 231,273 | 64,062 | 67.2 K to 64.1 K (-4.62 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 7,332 | 0 | 67,163 | 59.8 K to 67.2 K (+12.25 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 12,373 | 0 | 59,831 | 47.5 K to 59.8 K (+26.07 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Payment of Exercise | F | 74.58 | 3,817 | 284,672 | 98,010 | 101.8 K to 98 K (-3.75 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Grant | A | 0.00 | 9,331 | 0 | 101,827 | 92.5 K to 101.8 K (+10.09 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Grant | A | 0.00 | 18,392 | 0 | 92,496 | 74.1 K to 92.5 K (+24.82 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | HAVEL JAMES M | Executive VP and CF ... | Grant | A | 0.00 | 4,501 | 0 | 57,833 | 53.3 K to 57.8 K (+8.44 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | HAVEL JAMES M | Executive VP and CF ... | Grant | A | 0.00 | 18,392 | 0 | 53,332 | 34.9 K to 53.3 K (+52.64 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Payment of Exercise | F | 74.58 | 1,098 | 81,889 | 17,609 | 18.7 K to 17.6 K (-5.87 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Grant | A | 0.00 | 3,617 | 0 | 18,707 | 15.1 K to 18.7 K (+23.97 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Grant | A | 0.00 | 6,688 | 0 | 15,090 | 8.4 K to 15.1 K (+79.60 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Payment of Exercise | F | 74.58 | 2,950 | 220,011 | 48,983 | 51.9 K to 49 K (-5.68 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Grant | A | 0.00 | 8,637 | 0 | 51,933 | 43.3 K to 51.9 K (+19.95 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Grant | A | 0.00 | 16,720 | 0 | 43,296 | 26.6 K to 43.3 K (+62.91 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | Seiz Brian | Sr. VP, Specialty | Grant | A | 0.00 | 8,026 | 0 | 32,499 | 24.5 K to 32.5 K (+32.80 %) |
| Mar 08 2018 | ESRX | Express Scripts Ho ... | ARLOTTA JOHN | CEO, eviCore health ... | Grant | A | 0.00 | 6,688 | 0 | 6,688 | 0 to 6.7 K |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Option Exercise | M | 56.50 | 20,348 | 1,149,662 | 0 | |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Payment of Exercise | F | 74.77 | 17,253 | 1,290,007 | 58,572 | 75.8 K to 58.6 K (-22.75 %) |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Buy | M | 56.50 | 20,348 | 1,149,662 | 75,825 | 55.5 K to 75.8 K (+36.68 %) |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Option Exercise | M | 56.50 | 161,666 | 9,134,129 | 0 | |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Payment of Exercise | F | 74.77 | 140,078 | 10,473,632 | 840,748 | 980.8 K to 840.7 K (-14.28 %) |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Buy | M | 56.50 | 161,666 | 9,134,129 | 980,826 | 819.2 K to 980.8 K (+19.74 %) |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Option Exercise | M | 56.50 | 20,348 | 1,149,662 | 0 | |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 74.77 | 16,885 | 1,262,491 | 47,458 | 64.3 K to 47.5 K (-26.24 %) |
| Mar 06 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Buy | M | 56.50 | 20,348 | 1,149,662 | 64,343 | 44 K to 64.3 K (+46.25 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Sample Neal J. | Executive VP & COO | Payment of Exercise | F | 75.45 | 2,881 | 217,371 | 25,733 | 28.6 K to 25.7 K (-10.07 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Payment of Exercise | F | 75.45 | 965 | 72,809 | 26,576 | 27.5 K to 26.6 K (-3.50 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Payment of Exercise | F | 75.45 | 1,163 | 87,748 | 8,402 | 9.6 K to 8.4 K (-12.16 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Payment of Exercise | F | 75.45 | 1,163 | 87,748 | 8,402 | 9.6 K to 8.4 K (-12.16 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Payment of Exercise | F | 75.45 | 3,192 | 240,836 | 74,104 | 77.3 K to 74.1 K (-4.13 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Payment of Exercise | F | 75.45 | 3,192 | 240,836 | 74,104 | 77.3 K to 74.1 K (-4.13 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 75.45 | 1,917 | 144,638 | 43,995 | 45.9 K to 44 K (-4.18 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 75.45 | 1,917 | 144,638 | 43,995 | 45.9 K to 44 K (-4.18 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Payment of Exercise | F | 75.45 | 3,265 | 246,344 | 32,639 | 35.9 K to 32.6 K (-9.09 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Payment of Exercise | F | 75.45 | 1,791 | 135,131 | 31,924 | 33.7 K to 31.9 K (-5.31 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Payment of Exercise | F | 75.45 | 13,718 | 1,035,023 | 92,910 | 106.6 K to 92.9 K (-12.87 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Payment of Exercise | F | 75.45 | 2,970 | 224,087 | 55,477 | 58.4 K to 55.5 K (-5.08 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Payment of Exercise | F | 75.45 | 10,831 | 817,199 | 819,160 | 830 K to 819.2 K (-1.30 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Gift | G | 0.00 | 62,500 | 0 | 132,850 | 70.4 K to 132.9 K (+88.84 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Gift | G | 0.00 | 62,500 | 0 | 829,991 | 892.5 K to 830 K (-7.00 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Gift | G | 0.00 | 62,500 | 0 | 132,527 | 70 K to 132.5 K (+89.25 %) |
| Mar 02 2018 | ESRX | Express Scripts Ho ... | Paz George | Director | Gift | G | 0.00 | 62,500 | 0 | 892,491 | 955 K to 892.5 K (-6.54 %) |
| Feb 26 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Option Exercise | M | 54.59 | 3,646 | 199,035 | 0 | |
| Feb 26 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Payment of Exercise | F | 74.72 | 2,959 | 221,096 | 58,447 | 61.4 K to 58.4 K (-4.82 %) |
| Feb 26 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Buy | M | 54.59 | 3,646 | 199,035 | 61,406 | 57.8 K to 61.4 K (+6.31 %) |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Option Exercise | A | 0.00 | 696 | 0 | 2,388 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Option Exercise | A | 0.00 | 212 | 0 | 1,368 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | A | 0.00 | 172 | 0 | 1,501 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Sample Neal J. | Executive VP & COO | Option Exercise | A | 0.00 | 206 | 0 | 317 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Option Exercise | A | 0.00 | 214 | 0 | 729 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Neville Everett | Exe VP, Strat, Sup ... | Option Exercise | A | 0.00 | 185 | 0 | 890 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Option Exercise | A | 0.00 | 189 | 0 | 2,008 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Houston Christine | Executive Vice Pres ... | Option Exercise | A | 0.00 | 244 | 0 | 1,229 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | HAVEL JAMES M | Executive VP and CF ... | Option Exercise | A | 0.00 | 24 | 0 | 24 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | A | 0.00 | 155 | 0 | 340 | |
| Feb 05 2018 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Option Exercise | A | 0.00 | 219 | 0 | 461 | |
| Jan 12 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Sell | S | 81.00 | 3,449 | 279,369 | 33,715 | 37.2 K to 33.7 K (-9.28 %) |